Public awareness of the link between drinking alcohol and elevated cancer risk remains unchanged since February 2025, with over half of Americans saying that regularly consuming alcohol increases your chances of later developing ...
2 minutes ago
0
0
A study conducted at the University of Jyväskylä shows that regular leisure-time physical activity started at a young age prevents a decrease in work ability at the end of a career. The result is societally significant, ...
12 minutes ago
0
0
Researchers at Trinity College Dublin have found that a machine learning model could help clinicians predict which people with depression are more likely to improve with digital cognitive behavioral therapy compared to antidepressant ...
32 minutes ago
0
0
Researchers at Karolinska Institutet have created the first detailed map showing how genetic activity is controlled in individual cells of the adult human brain and spinal cord. The study, published in Nature Neuroscience, ...
52 minutes ago
0
0
The number of meningitis cases being probed by UK authorities has risen to 27, health officials said Thursday, following an unprecedented deadly outbreak centered on a university.
1 hour ago
0
0
Biomedical engineers from Brown University have developed a new wound dressing material that releases antibiotic drugs only when harmful bacteria are present in a wound. In the new study, published in the journal Science ...
1 hour ago
0
0
Scientists have uncovered a brain mechanism that may explain why chronic pain leads to depression in some people but not others, according to research published in Science. The findings challenge the idea that depression ...
1 hour ago
0
0
Researchers at UC Davis School of Medicine have uncovered how an imbalanced gut microbiome escalates the production of metabolic byproducts by certain gut bacteria. This imbalance drives a feedback loop that worsens chronic ...
1 hour ago
0
0
UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new class of supercharged T cells that are stronger, longer-lasting, and more ...
1 hour ago
0
0
Findings from two early clinical studies suggest a new dual-action antimalarial drug candidate is well tolerated in humans. The first-in-class clinical candidate, MK7602, is being developed by WEHI and global biopharmaceutical ...
1 hour ago
0
0
